Sheng Z, Wang L. Superiority of ibrutinib plus bendamustine and rituximab in newly diagnosed patients with mantle-cell lymphoma ineligible for intensive therapy: a network meta-analysis. Eur J Haematol 2023 Mar 14. doi: 10.1111/ejh.13953.
PMID: 36919283